InvestorsHub Logo
Followers 64
Posts 2029
Boards Moderated 0
Alias Born 10/31/2017

Re: None

Monday, 11/22/2021 6:53:25 AM

Monday, November 22, 2021 6:53:25 AM

Post# of 704163
Is Humira a platform technology?

You can’t call Humanized Monoclonal Antibodies a platform in the same sense that it is being applied to DCvax because each one does use different manufacturing steps. That may be called a platform technology, but it is not at all similar to DCVax. DCVax uses they same process every time or at least we assume that. They are only testing ONE Product for the past six years…no one would confuse that ONE Product for the Platform, because that is what actually matters.

What is your intent in promoting it and would it be confused by the consumer of that promotion as promoting an approved product or one that is coming soon?

Humira has approval in like 22 different indications, makes about $18-22B after rebates in those distinct diseases, and uses the same manufacturing process every time they produce a batch
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News